Reasons to Abandon Low-Density Lipoprotein Cholesterol Targets

Interviewed by Steven Greer, MD

Harlan Krumholz, MD, cardiologist from Yale, discusses his open letter in the journal Circulation recommending that LDL be scrapped as a treatment target for statins.

This entry was posted in - Policy, Cardiology, CMS, FDA, NIH, Yale. Bookmark the permalink.

Leave a Reply